These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28151024)

  • 1. Pulsed alexandrite laser for treatment of melasma in Asian patients.
    Cheng CY; Huang YL; Lee MC; Chang SL; Lin YF; Hu S
    J Cosmet Laser Ther; 2017 Aug; 19(4):210-214. PubMed ID: 28151024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
    Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
    Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
    Vachiramon V; Sirithanabadeekul P; Sahawatwong S
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Analysis of the Treatment of Melasma Using a Fractional Long-Pulsed Alexandrite Laser in Korean Patients.
    Lee MK; Min KS; Park EJ; Kim KH; Kim KJ
    Dermatol Surg; 2016 Aug; 42(8):952-60. PubMed ID: 27467229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Refractory Melasma in Asians With the Picosecond Alexandrite Laser.
    Polnikorn N; Tanghetti E
    Dermatol Surg; 2020 Dec; 46(12):1651-1656. PubMed ID: 32932271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin.
    Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY
    J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
    Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
    Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
    Zhou Y; Li Y; Hamblin MR; Wen X
    Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
    Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
    Chalermchai T; Rummaneethorn P
    J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
    Bernstein EF; Basilavecchio LD; Wang J
    Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.
    Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH
    J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
    Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
    Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.